S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Brainstorm Cell Therapeutics (BCLI) News Today

$0.22
-0.08 (-26.49%)
(As of 12/7/2023 ET)
Compare
Today's Range
$0.22
$0.27
50-Day Range
$0.15
$0.40
52-Week Range
$0.13
$3.46
Volume
6.01 million shs
Average Volume
1.09 million shs
Market Capitalization
$10.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
SourceHeadline
msn.com logoWhy BrainStorm Cell Therapeutics Shares Are Falling
msn.com - December 7 at 7:08 PM
finance.yahoo.com logoBrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS
finance.yahoo.com - December 7 at 9:06 AM
MarketBeat logoBrainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com
americanbankingnews.com - December 6 at 1:28 AM
morningstar.com logoBrainstorm Cell Therapeutics Inc BCLI
morningstar.com - November 28 at 6:16 PM
MarketBeat logoBrainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.com
americanbankingnews.com - November 28 at 1:10 AM
barrons.com logoINVESTOR ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLI
barrons.com - November 26 at 12:06 AM
barrons.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline -- BCLI
barrons.com - November 23 at 11:55 PM
benzinga.com logoBrainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Action
benzinga.com - November 21 at 9:10 PM
msn.com logoBrainstorm Cell Therapeutics (NASDAQ:BCLI) to Meet with FDA for New Treatment Plans
msn.com - November 21 at 8:50 AM
businesswire.com logoBCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
businesswire.com - November 20 at 3:06 PM
barrons.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLI
barrons.com - November 20 at 12:12 PM
markets.businessinsider.com logoBrainStorm Cell Therapeutics: FDA Grants In-person Meeting To Discuss Best Path Forward For NurOwn
markets.businessinsider.com - November 20 at 12:12 PM
finance.yahoo.com logoBrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
finance.yahoo.com - November 20 at 12:12 PM
finance.yahoo.com logoBrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia
finance.yahoo.com - November 17 at 7:10 AM
benzinga.com logoGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI)
benzinga.com - November 16 at 8:18 PM
finance.yahoo.com logoBCLI: Phase 3b Trial Details to be Discussed with FDA…
finance.yahoo.com - November 16 at 3:11 PM
finance.yahoo.com logoBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 15 at 6:16 PM
finance.yahoo.com logoQ3 2023 Brainstorm Cell Therapeutics Inc Earnings Call
finance.yahoo.com - November 15 at 8:11 AM
finanznachrichten.de logoBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - November 14 at 9:27 AM
finance.yahoo.com logoBrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 14 at 9:27 AM
businesswire.com logoBrainstorm Cell Therapeutics Inc. (BCLI) Investors: Shareholders with Large Losses Should Contact Robbins LLP Regarding the BCLI Class Action
businesswire.com - November 14 at 12:21 AM
benzinga.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc.(BCLI) Investors of a Class Action Lawsuit and Upcoming Deadline
benzinga.com - November 9 at 5:33 PM
businesswire.com logoGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Brainstorm Cell Therapeutics Inc. (BCLI) Investors
businesswire.com - November 8 at 9:15 PM
benzinga.com logoThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Brainstorm Cell Therapeutics Inc. (BCLI) Investors
benzinga.com - November 7 at 12:46 PM
finance.yahoo.com logoBrainStorm to Announce Third Quarter 2023 Financial Results and Provide a Corporate Update
finance.yahoo.com - November 7 at 7:35 AM
tmcnet.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investors
tmcnet.com - November 6 at 3:57 PM
benzinga.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. (BCLI) Investors of a Class Action Lawsuit and Upcoming Deadline
benzinga.com - November 6 at 3:57 PM
stockhouse.com logoBrainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc.
stockhouse.com - November 6 at 3:57 PM
businesswire.com logoThe Law Offices of Frank R. Cruz Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investors
businesswire.com - November 3 at 11:40 PM
benzinga.com logoShareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Brainstorm Cell Therapeutics Inc. (BCS)
benzinga.com - November 3 at 6:40 PM
benzinga.com logoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. (BCLI)
benzinga.com - November 2 at 7:53 PM
businesswire.com logoEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. – BCLI
businesswire.com - November 1 at 11:43 PM
finance.yahoo.com logoBrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS
finance.yahoo.com - October 24 at 8:32 AM
finance.yahoo.com logoBCLI: Meeting with FDA to Discuss Development Plan for NurOwn®…
finance.yahoo.com - October 23 at 3:36 PM
finance.yahoo.com logoBrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
finance.yahoo.com - October 18 at 8:01 AM
stockhouse.com logoROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI
stockhouse.com - October 9 at 9:38 AM
benzinga.com logoROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI
benzinga.com - October 7 at 2:53 PM
finance.yahoo.com logoBCLI: Advisory Panel Votes Against Recommending Approval of NurOwn®…
finance.yahoo.com - October 2 at 3:06 PM
proactiveinvestors.com logoBrainStorm shares plunge 56% after FDA advisers reject ALS cell therapy
proactiveinvestors.com - September 28 at 6:15 PM
proactiveinvestors.com logoBrainStorm shares plunge 56% after FDA advisors reject ALS cell therapy
proactiveinvestors.com - September 28 at 6:15 PM
tmcnet.com logoROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI
tmcnet.com - September 28 at 6:15 PM
msn.com logoFDA panel rejects ALS treatment from Brainstorm Cell Therapeutics
msn.com - September 28 at 8:15 AM
finance.yahoo.com logoBrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS
finance.yahoo.com - September 28 at 12:46 AM
finance.yahoo.com logoFDA advisers vote against experimental ALS treatment pushed by patients
finance.yahoo.com - September 27 at 7:46 PM
finanznachrichten.de logoBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Stock Trading Halted Today
finanznachrichten.de - September 27 at 9:44 AM
finance.yahoo.com logoBrainStorm Cell Therapeutics Stock Trading Halted Today
finance.yahoo.com - September 27 at 9:44 AM
marketbeat.com logo
marketbeat.com - September 27 at 6:58 AM
finance.yahoo.com logoBCLI: Public Support for NurOwn® from Prominent ALS Specialists…
finance.yahoo.com - September 26 at 6:43 PM
proactiveinvestors.com logoBrainStorm Cell plummets after FDA raises doubts over ALS therapy
proactiveinvestors.com - September 25 at 2:19 PM
msn.com logoWhy Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today?
msn.com - September 25 at 2:19 PM
Get Brainstorm Cell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter.



BCLI Media Mentions By Week

BCLI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCLI
News Sentiment

0.00

0.51

Average
Medical
News Sentiment

BCLI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCLI Articles
This Week

3

1

BCLI Articles
Average Week

Get Brainstorm Cell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BCLI) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -